Updates in Spinal Muscular Atrophy

Описание: This video is available for 0.50 AMA PRA Category 1 Credit(s)™
Click here to view CME and claim credit: https://www.francefoundation.com/cure...

Dr. Claudia Chiriboga shares highlights from a recent Cure SMA meeting focused on the spinal muscular atrophy treatments and patient management. Hear the impact of these latest developments.

Faculty Disclosures
The following faculty report that they have relevant financial relationships to disclose:
Dr. Claudia Chiriboga receives funding support from AveXis, Biogen, NIH, Roche, and SMA Foundation. She is also on the advisory board for AveXis, Cytokinetics, Genentech, PTC Therapeutics, and Roche.

The France Foundation resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

This information is intended for health care providers.

This activity is supported by an educational grant from Biogen.